1.
Kessler L, Falato C, Margolin S, Bergh J, Foukakis T. A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, Sweden. AO [Internet]. 2015 Apr. 21 [cited 2026 May 24];54(4):527-34. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26115